Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.